Latest News and Press Releases
Want to stay updated on the latest news?
-
Breaking Data posts an increase in consolidated revenues of 97%, the GIVEMESPORT team has made it seven successive quarters of revenue growth, with 70% increase in revenue in Fiscal Q4, resulting in...
-
HOUSTON, July 31, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug...
-
CINCINNATI, July 31, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today: GENERAL HIGHLIGHTS Reported record fiscal 2018 third quarter and first nine months net revenues of...
-
CRANBURY, N.J., July 31, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Tuesday, August 7, 2018 at...
-
Cash of $6.4 million generated from operationsNet income of $2.7 millionPhase Two expansion commencing production in Q3-2018 VANCOUVER, British Columbia, July 31, 2018 (GLOBE NEWSWIRE) -- Amerigo...
-
DEVON, Pa., July 31, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare...
-
CAMPBELL, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the second quarter of...
-
PHILADELPHIA, July 31, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a...
-
SAN DIEGO, July 31, 2018 (GLOBE NEWSWIRE) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today announced it will release second quarter 2018 financial results after the close of trading on Monday,...
-
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for August 9, 2018, 4:30 p.m. ET CORALVILLE, Iowa, July 31, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a...